Overview

Dapagliflozin in Mangement of Pulmonary Hypertension Patients

Status:
NOT_YET_RECRUITING
Trial end date:
2026-10-10
Target enrollment:
Participant gender:
Summary
Effect of SGLT2 (Dapagliflozin)on prognosis of patient with pulmonary Hypertension and Effect on RV function By speckle tract echocardiography at Assiut University Hospital.
Phase:
PHASE1
Details
Lead Sponsor:
Assiut University
Treatments:
dapagliflozin